AVEN anticorps
-
- Antigène Voir toutes AVEN Anticorps
- AVEN (Apoptosis, Caspase Activation Inhibitor (AVEN))
-
Reactivité
- Humain, Souris
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp AVEN est non-conjugé
-
Application
- Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
- Purification
- Affinity purification
- Immunogène
- Synthetic peptide of human AVEN
- Isotype
- IgG
- Top Product
- Discover our top product AVEN Anticorps primaire
-
-
- Indications d'application
- WB 1:500-1:2000, IHC 1:25-1:100
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 0.4 mg/mL
- Buffer
- PBS with 0.05 % sodium azide and 50 % glycerol, PH7.4
- Agent conservateur
- Sodium azide
- Conseil sur la manipulation
- Avoid freeze / thaw cycles.
- Stock
- -20 °C
- Stockage commentaire
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Antigène
- AVEN (Apoptosis, Caspase Activation Inhibitor (AVEN))
- Autre désignation
- AVEN (AVEN Produits)
- Synonymes
- anticorps AVEN, anticorps pdcd12, anticorps aven, anticorps wu:fc08c09, anticorps si:ch211-150c22.4, anticorps PDCD12, anticorps 1700013A01Rik, anticorps 1700056A21Rik, anticorps mAven-L, anticorps mAven-S, anticorps apoptosis and caspase activation inhibitor, anticorps apoptosis, caspase activation inhibitor L homeolog, anticorps apoptosis, caspase activation inhibitor, anticorps Aven, anticorps AVEN, anticorps aven.L, anticorps aven
- Sujet
- AVEN, a cell death regulator, is an important signal inducer in acute leuke-mias. AVEN is a highly conserved peripheral membrane protein that protects the cell against the proteolytic activation of caspases as well as Apaf-1 mediated apoptosis by interfering with Apaf-1's ability to self-associate. Bcl-2 and Bad also interact with AVEN to prevent apoptosis. AVEN is highly expressed in ovary, heart, thymus, spleen, testis and colon, but can also be detected in other tissues. Erythropoietin and methylprednisolone may play important roles in the expression of AVEN in cardiac tissue, especially after a traumatic brain injury. In young patients suffering from acute lymphoblastic leukemia (ALL), AVEN expression may be a useful tool in prognosis prediction.
- Poids moléculaire
- Calculated MW: 39 kDa
- NCBI Accession
- NP_065104
-